Beacon Pointe Advisors »

Relmada Therapeutics shares owned by Beacon Pointe Advisors

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Beacon Pointe Advisors from 13F filings

Historical chart of Beacon Pointe Advisors investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Beacon Pointe Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Beacon Pointe Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 10k 3.24
2024-06-30 $30k 10k 3.00

More positions owned by Beacon Pointe Advisors

Apple Call Option (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Amazon (AMZN)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Beacon Pointe Advisors

Top funds holding Relmada Therapeutics

Franklin Resources
Vanguard Group
Deep Track Capital
Acadian Asset Management
Parsons Capital Management
Palo Alto Investors
BlackRock
BlackRock
Vestal Point Capital
Opaleye Management
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Advisers
Deutsche Bank Aktiengesellschaft
Bank of America Corporation

View all funds holding Relmada Therapeutics